[DPHARMA] QoQ Cumulative Quarter Result on 31-Mar-2017 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-May-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Mar-2017 [#1]
Profit Trend
QoQ- -68.22%
YoY- 9.88%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 467,987 355,734 240,355 120,994 312,940 238,907 158,605 105.31%
PBT 51,796 38,971 24,764 11,176 31,479 25,180 17,664 104.46%
Tax -9,696 -8,639 -5,559 -2,558 -4,653 -7,185 -5,895 39.21%
NP 42,100 30,332 19,205 8,618 26,826 17,995 11,769 133.35%
-
NP to SH 42,492 30,622 19,217 8,618 27,115 18,867 12,346 127.44%
-
Tax Rate 18.72% 22.17% 22.45% 22.89% 14.78% 28.53% 33.37% -
Total Cost 425,887 325,402 221,150 112,376 286,114 220,912 146,836 102.98%
-
Net Worth 479,809 474,230 463,071 463,071 454,703 451,913 446,334 4.92%
Dividend
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Div 23,711 - 6,973 - 18,132 - 6,973 125.62%
Div Payout % 55.80% - 36.29% - 66.87% - 56.49% -
Equity
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Net Worth 479,809 474,230 463,071 463,071 454,703 451,913 446,334 4.92%
NOSH 278,959 278,959 278,959 278,959 278,959 278,959 278,959 0.00%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 9.00% 8.53% 7.99% 7.12% 8.57% 7.53% 7.42% -
ROE 8.86% 6.46% 4.15% 1.86% 5.96% 4.17% 2.77% -
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 167.76 127.52 86.16 43.37 112.18 85.64 56.86 105.30%
EPS 15.09 10.87 6.88 3.43 9.62 6.45 4.22 133.29%
DPS 8.50 0.00 2.50 0.00 6.50 0.00 2.50 125.60%
NAPS 1.72 1.70 1.66 1.66 1.63 1.62 1.60 4.92%
Adjusted Per Share Value based on latest NOSH - 278,959
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 48.61 36.95 24.97 12.57 32.51 24.82 16.48 105.26%
EPS 4.41 3.18 2.00 0.90 2.82 1.96 1.28 127.60%
DPS 2.46 0.00 0.72 0.00 1.88 0.00 0.72 126.34%
NAPS 0.4984 0.4926 0.481 0.481 0.4723 0.4694 0.4636 4.92%
Price Multiplier on Financial Quarter End Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 -
Price 2.53 2.20 2.25 2.31 1.98 2.06 2.04 -
P/RPS 1.51 1.73 2.61 5.33 1.76 2.41 3.59 -43.77%
P/EPS 16.61 20.04 32.66 74.77 20.37 30.46 46.09 -49.26%
EY 6.02 4.99 3.06 1.34 4.91 3.28 2.17 97.06%
DY 3.36 0.00 1.11 0.00 3.28 0.00 1.23 95.05%
P/NAPS 1.47 1.29 1.36 1.39 1.21 1.27 1.28 9.63%
Price Multiplier on Announcement Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 28/02/18 17/11/17 25/08/17 22/05/17 24/02/17 21/11/16 22/08/16 -
Price 2.97 2.20 2.03 2.32 2.23 2.10 2.14 -
P/RPS 1.77 1.73 2.36 5.35 1.99 2.45 3.76 -39.40%
P/EPS 19.50 20.04 29.47 75.10 22.94 31.05 48.35 -45.32%
EY 5.13 4.99 3.39 1.33 4.36 3.22 2.07 82.82%
DY 2.86 0.00 1.23 0.00 2.91 0.00 1.17 81.16%
P/NAPS 1.73 1.29 1.22 1.40 1.37 1.30 1.34 18.51%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment